[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 25, Issue 6 (Bimonthly 2021) ::
Feyz 2021, 25(6): 1294-1302 Back to browse issues page
Evaluation of antioxidant effects of harmaline in NMRI diabetic male mice
Maryam Yaghoubi , Hanieh Jafary * , Parichehreh Yaghmaei
Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, I.R. Iran. , h-jafary@srbiau.ac.ir
Abstract:   (338 Views)
Background: Diabetes is a metabolic disease that can causes complications such as oxidative stress and decreased levels of antioxidant enzymes. In researches, it has been found that the alcoholic extract of pecan is effective in the treatment of diabetes. Harmaline is an alkaloid of pecan extract, which has antioxidant properties. In this study, models of type 1 diabetic mice were used to evaluate the properties of harmaline.
Materials and Methods: In this study, 40 male NMRI mice were used. Mice were divided into 5 groups of eight including control (ordinary food and water recipient), diabetic (mice that became diabetic with streptozotocin), sham (diabetic mice received only the solvent of harmalin, distilled water, during the experimental stages), experimental groups 1(50 mg/kg harmaline) and 2 (100 mg/kg harmaline). At the end of the harmaline treatment period, the animals were anesthetized with ether and blood samples were taken from all groups. Glucose, insulin, lipid profile, malondialdehyde (MDA), superoxide dismutase (SOD) and catalase (CAT) were measured in rat serum. Sampling of pancreatic tissue was performed using western blotting method to measure insulin changes in experimental groups.
Results: The levels of insulin, HDL, superoxide dismutase and catalase in treatment groups had a significant increase and the levels of glucose, MDA, LDL and cholesterol in treatment groups showed a significant decrease.
Conclusion: Treatment of mice with harmaline can improves the condition of diabetic animals.
Keywords: Harmaline, Antioxidant, Diabetes, Antioxidant enzyme
Full-Text [PDF 389 kb]   (114 Downloads)    
Type of Study: Research | Subject: General
Received: 2021/03/31 | Accepted: 2021/11/3 | Published: 2022/02/1
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Yaghoubi M, Jafary H, Yaghmaei P. Evaluation of antioxidant effects of harmaline in NMRI diabetic male mice. Feyz. 2021; 25 (6) :1294-1302
URL: http://feyz.kaums.ac.ir/article-1-4372-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 25, Issue 6 (Bimonthly 2021) Back to browse issues page
مجله علمی پژوهشی فیض ::: دانشگاه علوم پزشکی کاشان KAUMS Journal ( FEYZ )
Persian site map - English site map - Created in 0.04 seconds with 30 queries by YEKTAWEB 4410